Anne Corlu
Impact in
- Hepatology top 1%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
- Hepatology 33
- Liver physiology and pathology 30
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Pharmacology 15
- Drug-Induced Hepatotoxicity and Protection 12
- Pharmacogenetics and Drug Metabolism 6
- Co-authors
- Christiane Guguen‐Guillouzo (37 shared papers)Denise Glaise (19 shared papers)André Guillouzo (5 shared papers)Caroline Aninat (16 shared papers)Fabrice Morel (10 shared papers)Pascal Loyer (22 shared papers)Melina M. Malinen (3 shared papers)Marjo L. Yliperttula (3 shared papers)
- Journals
- Hepatology (6 papers)Journal of Hepatology (3 papers)Cell Death and Disease (3 papers)Cells (3 papers)Biomaterials (3 papers)
- Partner nations
- FranceIvory CoastUnited States
In The Last Decade
Anne Corlu
107 papers receiving 4.6k citations
Anne Corlu's Hit Papers
Peers
Comparison fields: 5 of 119
- Hepatology 822
- Pharmacology 771
- Biomaterials 331
- Molecular Medicine 135
- Oncology 411
Countries citing papers authored by Anne Corlu
This map shows the geographic impact of Anne Corlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Corlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Corlu more than expected).
Fields of papers citing papers by Anne Corlu
This network shows the impact of papers produced by Anne Corlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Corlu. The network helps show where Anne Corlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Corlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics Hit paper breakdown → | 2006 | 538 |
| 2 | 2012 | 366 | |
| 3 | 2007 | 298 | |
| 4 | 2012 | 178 | |
| 5 | 2014 | 176 | |
| 6 | 2014 | 169 | |
| 7 | 2008 | 108 | |
| 8 | 2002 | 100 | |
| 9 | 2012 | 99 | |
| 10 | 2009 | 96 | |
| 11 | 2006 | 94 | |
| 12 | 2011 | 93 | |
| 13 | 1991 | 80 | |
| 14 | 2009 | 80 | |
| 15 | 2013 | 79 | |
| 16 | 2014 | 75 | |
| 17 | 1996 | 69 | |
| 18 | 2021 | 68 | |
| 19 | 2010 | 67 | |
| 20 | 2005 | 64 |
About Anne Corlu
Anne Corlu is a scholar working on Hepatology, Pharmacology, Molecular Biology, Oncology and Hematology, having authored 108 papers that have together received 4.7k indexed citations. Recurring topics across this work include Liver physiology and pathology (30 papers), Drug-Induced Hepatotoxicity and Protection (12 papers), Synthesis and biological activity (7 papers), 3D Printing in Biomedical Research (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Pharmacogenetics and Drug Metabolism (6 papers), Cancer Cells and Metastasis (6 papers) and Pluripotent Stem Cells Research (4 papers). The work is most often cited by research in Hepatology (822 citations), Pharmacology (771 citations), Biomaterials (331 citations), Molecular Medicine (135 citations) and Oncology (411 citations). Anne Corlu has collaborated with scholars based in France, Ivory Coast and United States. Frequent co-authors include Christiane Guguen‐Guillouzo, Denise Glaise, André Guillouzo, Caroline Aninat, Fabrice Morel, Pascal Loyer, Melina M. Malinen, Marjo L. Yliperttula, Yan‐Ru Lou and Liisa K. Kanninen. Their work appears in journals such as Hepatology, Journal of Hepatology, Cell Death and Disease, Cells and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.